|

Azacitidine Injection Clinical Trials

3 actively recruiting trials

Also known as: Azacitidine

Pipeline

Phase 2: 2Phase 3: 1

Top Sponsors

  • Ludwig-Maximilians - University of Munich1
  • Children's Hospital of Soochow University1
  • Ascentage Pharma Group Inc.1

Indications

  • Cancer3
  • Acute Myeloid Leukemia2
  • C-KIT Mutation1
  • Core Binding Factor Acute Myeloid Leukemia1
  • Refractory AML1

Other3 trials

A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
Phase 3
Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML
Phase 2
Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.